skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Thrombin use in surgery: an evidence-based review of its clinical use

Review

(1796) Views  (721) Full article downloads

Authors: Sung W Ham, Wesley K Lew, Fred A Weaver

Published Date July 2010 Volume 2010:1 Pages 135 - 142
DOI: http://dx.doi.org/10.2147/JBM.S6622

Sung W Ham1, Wesley K Lew1, Fred A Weaver2

1University of Southern California, Department of Surgery, Los Angeles, CA, 2Cardiovascular Thoracic Institute at the University of Southern California, Los Angeles, USA

Abstract: When surgical ligation of bleeding fails, or is not possible, surgeons rely on a ­number of hemostatic aids, including thrombin. This review discusses the history, pharmacology and clinical application of thrombin as a surgical hemostat. The initial thrombin was bovine in origin, but its use has been complicated by the formation of antibodies that cross-react with human coagulation factors. This has been associated with life-threatening bleeding and in some circumstances anaphylaxis and death. Human thrombin, isolated from pooled plasma of donors, was developed in an effort to minimize these risks, but its downsides are its limited availability and the potential for transmitting blood-borne pathogens. Recently a recombinant thrombin has been developed, and approved for use by the FDA. It has the advantage of being minimally antigenic and devoid of the risk of viral transmission. Thrombin is often used in conjunction with other hemostatic aids, including absorbable agents such as Gelfoam, and with fibrinogen in fibrin glues. The last part of this review will discuss these agents in detail, and review their clinical applications.

Keywords: bovine, recombinant, human, thrombin, antigenicity, antibodies, food drug ­administration (FDA)





 

Other articles by Dr Fred Weaver



Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Potential renovascular hypertension, space missions, and the role of magnesium
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Everolimus-eluting stents: update on current clinical studies
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio